Health News

Certain Seizure Meds Safer Than Others
There are a number of medications used to treat epilepsy. Some of these anti-seizure medications have been shown to increase heart disease risks. New research shows epilepsy patients may have safer choices.
Epilepsy Drug Linked to Autism
The exact causes of autism are still not known, and much of how the disorder develops remain a mystery. Many studies point to prenatal development links.
FDA approves Onfi to treat severe type of seizures
On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets ( clobazam ) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older.
Which Is Best, Surgery Or Medication?
Some forms of epilepsy are tough to treat with just a medication. A new study demonstrates that brain surgery is a viable alternative to medication therapies.
Hyperventilating May Cause Childhood Seizures
Pediatricians are very focused on their patients avoiding extended high fevers for many health reasons. One of their concerns is that fevers can cause a febrile seizure.
New View of Vitamin C
Vitamin C has long been touted as a super antioxidant. Maybe you've even taken some at the first sign of cold. Now scientists are finding that vitamin C offers a surprising benefit.
Epilepsy Drug Trial May Have Been Sales Tactic
Yale School of Medicine researchers have discovered that a clinical trial of epilepsy drug gabapentin (trade name Neurontin) may have actually been a promotional and sales move to increase prescriptions of the medicine.
Electrical Brain-storming
In an interesting twist, researchers discovered about a decade ago that many of the brain patterns seen in epilepsy are also seen in children with autism.
FDA Approves New Epilepsy Drug
The U.S. Food and Drug Administration has given the green light to a new Epilepsy drug that will aid with seizure control in adults.
Drug Resistent Epilepsy Responds to Stimulation
Pharmaceutical treatment of epilepsy is the predominant therapy for most patients. For an estimated one million patients with epilepsy, these drugs simply don't work.